Replies to post #187734 on Biotech Values

[DewDiligence]

DPRX sells 1.70M* shares @$12.50—a 10% discount to yesterday’s close:

http://finance.yahoo.com/news/dipexium-announces-pricing-public-offering-131200520.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

DPRX has completed two phase-3 trials of Locilex and will report results during late October:

http://finance.yahoo.com/news/dipexium-provides-availability-results-pivotal-110000275.html

Yes, this is the same Locilex that failed in clinical trials almost 15 years ago.